Medicare: Individual Drug Review, Not Class-Based Assessments
New Medicare rules change how drugs are evaluated. Instead of assessing entire drug classes, each drug will now be individually reviewed for its necessity and reasonableness. This aims to ensure that coverage decisions are more precise and tailored to specific products, potentially affecting drug availability and costs for patients.
Key points
Each drug will be individually assessed by Medicare, not as part of a larger group.
The change aims for more precise determination of whether a drug is necessary and justified.
This may impact which drugs are covered by Medicare and under what conditions.
Expired
Citizen Poll